The overall mission ofthe UCSD/UCLA DRC confinues to center on fostering research in the prevention and treatment of diabetes and its complicafions to ultimately improve the lives of patierits. For the past decade, our DRC has been unique in linking together the diabetes/metabolism activifies of two major universities within the UC system. We believe this has been a novel, and a very successful effort;Thus, we have been able harness the collective energy and scientific excitement at UCSD/Salk and UCLA/Cedars-Sinai, which comprise the major proportion of research in diabetes/metabolism in Southern California. The DRC has fostered new collaborations and interactions between outstanding scienfists within and across these insfitutions and has played an important role in promofing the careers of young scienfists as they move on to the status of independent invesfigators. Our research base faculty membership now includes 109 outstanding scienfists who have been excepfionally successful as can be judged by the numerous publicafions in high impact journals and the generous peer review grant support that they have accrued ($155 million dollars). Some selective highlights over the past four years include: (1) Organizafion of the Pediatric Diabetes Research Center (PDRC) at UCSD along with the addifion of the La Jolla Allergy and Immunology Institute (LIAI) on the UCSD campus, which brings a number of outstanding new faculty into the DRC, all focused exclusively on type 1 diabetes research. (2) Establishment and occupancy of the Institute for Regenerative Medicine on the UCSD campus which has a focus on human stem cell research and beta cell generafion (3) Major recruitments and addifion of diabetes/metabolism-based scientists at both UCLA and UCSD. For example, this includes Richard Bergman and Marilyn Ader, and their respecfive groups, at Cedars-Sinai, Kumar Sharma at UCSD, and Matthias von Herrath at LIAI. (4) Outstanding success of our P&F awardees as they move fonward and upward in their scientific careers. An acknowledgement of this, UCSD and UCLA have agreed to provide $100,000/year in unrestricted funds to augment our P&F program. (5) Establishment and confinuafion of several program project grants and center among our collaborafing DRC faculty, headed by Drs. Chris Glass, Pam Mellon, Susan Taylor, Aldons Lusis, Joe Witztum, and Steve Young. All of our Research cores have been updated with new services and state-of-the-art technologies in the upcoming project period. In addifion, we have added a new Novel Target Discovery and Assay Development Core to reflect the many advances in this field as they relate to diabetes and metabolism research.

Public Health Relevance

of the UCSD/UCLA DRC is promotion and enhancement of research into the mechanisms, etiology, pathophysiology, treatment, and prevention of diabetes mellitus and its complications and related metabolic disorders through the outstanding scientific accomplishments ofthe faculty comprising our research base, our biomedical research cores, the P&F Program, and the Enrichment Program and Administrative Cores. Our firm conviction is that success will ultimately improve the lives of patients with diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Center Core Grants (P30)
Project #
5P30DK063491-12
Application #
8641346
Study Section
Special Emphasis Panel (ZDK1-GRB-S)
Project Start
Project End
Budget Start
2014-05-01
Budget End
2015-04-30
Support Year
12
Fiscal Year
2014
Total Cost
$233,514
Indirect Cost
$56,768
Name
University of California San Diego
Department
Type
DUNS #
804355790
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Maggi, Maristella; Mittelman, Steven D; Parmentier, Jean Hugues et al. (2017) A protease-resistant Escherichia coli asparaginase with outstanding stability and enhanced anti-leukaemic activity in vitro. Sci Rep 7:14479
Kerr, Kathleen F; Avery, Christy L; Lin, Henry J et al. (2017) Genome-wide association study of heart rate and its variability in Hispanic/Latino cohorts. Heart Rhythm 14:1675-1684
Graff, Mariaelisa; Emery, Leslie S; Justice, Anne E et al. (2017) Genetic architecture of lipid traits in the Hispanic community health study/study of Latinos. Lipids Health Dis 16:200
Wang, Jiexin; Rajbhandari, Prashant; Damianov, Andrey et al. (2017) RNA-binding protein PSPC1 promotes the differentiation-dependent nuclear export of adipocyte RNAs. J Clin Invest 127:987-1004
Sobrin, Lucia; Chong, Yong He; Fan, Qiao et al. (2017) Genetically Determined Plasma Lipid Levels and Risk of Diabetic Retinopathy: A Mendelian Randomization Study. Diabetes 66:3130-3141
Ying, Wei; Wollam, Joshua; Ofrecio, Jachelle M et al. (2017) Adipose tissue B2 cells promote insulin resistance through leukotriene LTB4/LTB4R1 signaling. J Clin Invest 127:1019-1030
Xie, Huimin; Hoffmann, Hanne M; Iyer, Anita K et al. (2017) Chromatin status and transcription factor binding to gonadotropin promoters in gonadotrope cell lines. Reprod Biol Endocrinol 15:86
Gosselin, David; Skola, Dylan; Coufal, Nicole G et al. (2017) An environment-dependent transcriptional network specifies human microglia identity. Science 356:
Hernandez-Carretero, A; Weber, N; La Frano, M R et al. (2017) Obesity-induced changes in lipid mediators persist after weight loss. Int J Obes (Lond) :
Rong, Xin; Wang, Bo; Palladino, Elisa Nd et al. (2017) ER phospholipid composition modulates lipogenesis during feeding and in obesity. J Clin Invest 127:3640-3651

Showing the most recent 10 out of 781 publications